These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10742382)

  • 1. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N; Hatzfeld J; Kisselev S; Monier MN; Ducos K; Cardoso A; Batard P; Hatzfeld A
    Stem Cells; 2000; 18(2):102-11. PubMed ID: 10742382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells.
    Ducos K; Hatzfeld A; Héron A; Fortunel N; Kisselev S; Héron C; Monier MN; Hatzfeld J
    Gene Ther; 2000 Oct; 7(20):1790-4. PubMed ID: 11083502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
    Ducos K; Panterne B; Fortunel N; Hatzfeld A; Monier MN; Hatzfeld J
    J Cell Physiol; 2000 Jul; 184(1):80-5. PubMed ID: 10825236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and release from quiescence of umbilical cord blood early progenitors reveal their potential to engraft adults.
    Hatzfeld J; Batard P; Cardoso AA; Li ML; Panterne B; Sansilvestri P; Ginsbourg M; Levesque JP; Hatzfeld A
    Blood Cells; 1994; 20(2-3):430-4; discussion 434-5. PubMed ID: 7538349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
    Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
    Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-augmented culture of haematopoietic progenitor cells in a novel three-dimensional cell growth matrix.
    Banu N; Rosenzweig M; Kim H; Bagley J; Pykett M
    Cytokine; 2001 Mar; 13(6):349-58. PubMed ID: 11292318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D; Tang XM; Ma C; Chegini N
    Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral vector design for high-level transgene expression in primitive human hematopoietic progenitors.
    Fan X; Brun A; Karlsson S
    Gene Ther; 2000 Dec; 7(24):2132-8. PubMed ID: 11223995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin II on hematopoietic progenitor cell proliferation.
    Rodgers KE; Xiong S; Steer R; diZerega GS
    Stem Cells; 2000; 18(4):287-94. PubMed ID: 10924095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neutralizing anti-TGF-beta1 antibody promotes proliferation of CD34+Thy-1+ peripheral blood progenitors and increases the number of transduced progenitors.
    Imbert AM; Bagnis C; Galindo R; Chabannon C; Mannoni P
    Exp Hematol; 1998 May; 26(5):374-81. PubMed ID: 9590653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo.
    Larsson J; Blank U; Klintman J; Magnusson M; Karlsson S
    Exp Hematol; 2005 May; 33(5):592-6. PubMed ID: 15850837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine stromal cell line HESS-5 maintains reconstituting ability of Ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood.
    Shimakura Y; Kawada H; Ando K; Sato T; Nakamura Y; Tsuji T; Kato S; Hotta T
    Stem Cells; 2000; 18(3):183-9. PubMed ID: 10840071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.
    Dooley S; Delvoux B; Lahme B; Mangasser-Stephan K; Gressner AM
    Hepatology; 2000 May; 31(5):1094-106. PubMed ID: 10796885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.